Home › NDC Lookup › RxCUI directory › RxCUI 200082

Lamivudine 150 MG / zidovudine 300 MG Oral Tablet — RxCUI 200082

RxNorm drug concept · Semantic clinical drug
RxCUI 200082 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 19 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI200082
Official nameLamivudine 150 MG / zidovudine 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as3TC 150 MG / AZT 300 MG Oral Tablet
FDA products mapped10
Package NDCs mapped19
Reported Medicaid activity (SDUD)582 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lamivudine and Zidovudine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, lamivudine and zidovudine doesn't cure HIV. What it does is help control it. The two drugs in this tablet block an enzyme HIV needs to make copies of itself. Less copying means...
  • What exactly does this medicine do — does it cure HIV?
  • No — this tablet always needs to be taken alongside at least one other antiretroviral medicine. Using it alone isn't recommended because HIV is more likely to develop resistance an...
  • Can I take this tablet on its own to treat my HIV?
📖 Read our full Lamivudine and Zidovudine guide →

🕸️ Concept Web — How Lamivudine 150 MG / zidovudine 300 MG Oral Table... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lamivudine 150 MG / zidovudine 300 MG Oral Tablet RxCUI 200082

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Lamivudine 68244
    • Zidovudine 11413
    • Lamivudine / zidovudine 214671
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Combivir 192254
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lamivudine / zidovudine Oral Tablet 372564
    • Lamivudine / zidovudine Oral Product 1162816
    • Lamivudine / zidovudine Pill 1162817
    • Lamivudine / zidovudine Oral Tablet [Combivir] 368309
    • Combivir Oral Product 1166890
    • Combivir Pill 1166891
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lamivudine 150 MG SCDC · 316127
  • Zidovudine 300 MG SCDC · 316916
  • Lamivudine / zidovudine Oral Tablet SCDF · 372564
  • Lamivudine / zidovudine Oral Product SCDG · 1162816
  • Lamivudine / zidovudine Pill SCDG · 1162817

Brand-Name Concepts

📦 FDA Products & Package NDCs

10 products · 19 package NDCs
19 package NDCs map to RxCUI 200082 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0506-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-506-05) LAMIVUDINE and ZIDOVUDINE Camber Pharmaceuticals, Inc. 2015-09-18
31722-0506-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-506-60) LAMIVUDINE and ZIDOVUDINE Camber Pharmaceuticals, Inc. 2015-09-18
31722-0739-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-739-05) Lamivudine and Zidovudine Camber Pharmaceuticals, Inc. 2014-02-06
31722-0739-31 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-739-31) Lamivudine and Zidovudine Camber Pharmaceuticals, Inc. 2014-02-06
31722-0739-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-739-60) Lamivudine and Zidovudine Camber Pharmaceuticals, Inc. 2014-02-06
33342-0003-09 60 TABLET in 1 BOTTLE (33342-003-09) Lamivudine and Zidovudine Macleods Pharmaceuticals Limited 2018-08-30
43063-0900-06 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-900-06) LAMIVUDINE and ZIDOVUDINE PD-Rx Pharmaceuticals, Inc. 2018-10-11
49702-0202-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18) COMBIVIR ViiV Healthcare Company 2010-10-19
65862-0036-10 6 BLISTER PACK in 1 CARTON (65862-036-10) / 10 TABLET, FILM... Lamivudine and Zidovudine Aurobindo Pharma Limited 2017-05-05
65862-0036-60 60 TABLET, FILM COATED in 1 BOTTLE (65862-036-60) Lamivudine and Zidovudine Aurobindo Pharma Limited 2017-05-05
71335-0639-01 6 TABLET, FILM COATED in 1 BOTTLE (71335-0639-1) LAMIVUDINE and ZIDOVUDINE Bryant Ranch Prepack 2021-04-02
71335-0639-02 60 TABLET, FILM COATED in 1 BOTTLE (71335-0639-2) LAMIVUDINE and ZIDOVUDINE Bryant Ranch Prepack 2021-12-27
71335-0639-03 4 TABLET, FILM COATED in 1 BOTTLE (71335-0639-3) LAMIVUDINE and ZIDOVUDINE Bryant Ranch Prepack 2021-12-27
71335-1916-01 6 TABLET in 1 BOTTLE (71335-1916-1) Lamivudine and Zidovudine Bryant Ranch Prepack 2021-07-15
71335-1916-02 60 TABLET in 1 BOTTLE (71335-1916-2) Lamivudine and Zidovudine Bryant Ranch Prepack 2024-04-05
71335-1916-03 4 TABLET in 1 BOTTLE (71335-1916-3) Lamivudine and Zidovudine Bryant Ranch Prepack 2024-04-05
72865-0144-60 60 TABLET, FILM COATED in 1 BOTTLE (72865-144-60) LAMIVUDINE AND ZIDOVUDINE XLCare Pharmaceuticals, Inc 2020-04-17
76282-0115-05 500 TABLET, FILM COATED in 1 BOTTLE (76282-115-05) Lamivudine and Zidovudine Exelan Pharmaceuticals Inc. 2015-04-29
76282-0115-60 60 TABLET, FILM COATED in 1 BOTTLE (76282-115-60) Lamivudine and Zidovudine Exelan Pharmaceuticals Inc. 2015-04-29
Observed labelers: Bryant Ranch Prepack (6) · Camber Pharmaceuticals, Inc. (5) · Aurobindo Pharma Limited (2) · Exelan Pharmaceuticals Inc. (2) · Macleods Pharmaceuticals Limited (1) · PD-Rx Pharmaceuticals, Inc. (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.